Purchase Order 75N94024P00038
Award Date 12/24/23
Potential Completion Date 12/23/24
Potential Value $48K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA), operating under the National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health, awarded a $143,677 purchase order to Illumina, Inc. for a NextSeq 2000 maintenance agreement. The contract, awarded on December 24, 2024, with an ultimate completion date of December 23, 2026, covers one base year plus two option years of comprehensive maintenance and support services for the NextSeq 2000...
- The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing equipment and consumables, to provide a NextSeq 2000 Sequencing System and associated services for $248,675.00. The contract has no set-aside designation. This purchase order was issued under a sole source solicitation, as the NextSeq 2000 system is the only platform...
- Illumina, Inc. was awarded a $48,209 firm fixed price purchase order for a NEXTSEQ 2000 SILVER SUPPORT PLAN by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The support plan is for a NEXTSEQ 2000 sequencing system located at the agency's facilities in Bethesda, Maryland and provides maintenance services for the proprietary instrumentation through March 2025. No set-aside provision was applied to this acquisition of sequencing system support from the...
- The National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism awarded a $13,069 delivery order to Illumina, Inc. of San Diego, California. The order is for NovaSeq 6000 S4 reagent kits to support the agency's biomedical research efforts. Illumina will provide the sequencing consumables to NIH-NIAAA under a firm fixed price arrangement, with performance taking place in San Diego through October 2022. No subcontractors or set-aside designations were indicated. The...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $36,117 firm fixed price purchase order to Illumina, Inc. to provide a NEXTSEQ 1000 SILVER SUPPORT PLAN. The place of performance is Potomac, Maryland and the period of performance is from December 1, 2023 through November 30, 2024. This support plan is likely associated with the NIH's ongoing genomic sequencing and bioinformatics research efforts to...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $25,959 purchase order to Illumina, Inc. to provide a NEXTSEQ 2000 SERVICE AGREEMENT. The contract has a firm fixed price and period of performance from September 29, 2023 through September 28, 2024. The original solicitation sought a service contract for NEXTSEQ 2000 maintenance and support services. As the prime contractor, Illumina will deliver these services for the...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,171 firm fixed price purchase order to Illumina, Inc. for the annual renewal of the NextSeq bronze support plan. As a manufacturer and provider of sequencing and array-based solutions, Illumina will deliver maintenance services for the NextSeq sequencing system located in Rockville, Maryland under this contract. No set-aside provision was utilized for this...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for a NextSeq 2000 Bronze Support Plan on July 12, 2026, with a ceiling value of $25,959.00. The order is a firm fixed-price, non-severable commercial item acquisition with no small business set-aside. Place of performance is Bethesda, Maryland. The support plan covers maintenance and technical support for the NextSeq 2000 sequencing instrument through the ultimate completion date of July 11,...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan and Preventive Maintenance with a total ceiling value of $23,717.81. The award does not utilize any set-aside designations. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has received prior prime federal contract and sub-grant awards...
- Illumina, Inc. was awarded a $21,662.50 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to provide an Illumina NextSeq 500 Health Check and Service Agreement. As the sole manufacturer of the NextSeq 500 sequencing platform, Illumina will deliver maintenance and support services for the sequencer located in San Diego, California under this contract. No subcontractors or set-aside provisions were specified. The award is likely in support of...